Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by derekli

Order by:

BLUSD	wait,seems Auven Therapeutics pay the KICATA's fees seems the partner Auven Therapeutics pays the fee, the loss is... June 24, 2016
BLUSD	RE:July 6 .... May be to give them a chance show the data and the result to market,to... June 24, 2016
BLUSD	The papeline,KIACTA™ sarcoidosis and Shigamab™ June 23, 2016
BLUSD	I will wait for Shigamab In addition, BELLUS Health is developing Shigamab™, an antibody treatment for... June 23, 2016
BLUSD	The company still has 9 million on hand market cap is 21m, they still can do a lot of thing June 23, 2016
BLUSD	The history. I will wait until 2020 LAVAL, QC, Feb. 26 /PRNewswire-FirstCall/ - BELLUS Health Inc. (TSX: BLU... June 23, 2016

Featured News Links

Options Trading for Retiring: Key Strategies in Balancing Retirement Income

One Property, One Focus on Advancing this Gold Project in Ontario

Featured Company

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »